Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
50 巻, 2 号
選択された号の論文の23件中1~23を表示しています
ORIGINAL ARTICLES
  • Taku Tabata, Terumi Kamisawa, Kensuke Takuma, Naoto Egawa, Keigo Setog ...
    2011 年 50 巻 2 号 p. 69-75
    発行日: 2011年
    公開日: 2011/01/15
    ジャーナル オープンアクセス
    Objective Autoimmune pancreatitis (AIP) and Mikulicz's disease have recently been recognized as pancreatic or salivary gland lesions of IgG4-related systemic disease. These are frequently associated with elevated serum IgG4 levels. This study aimed to clarify clinical implications of serial changes of elevated serum IgG4 levels in IgG4-related systemic diseases.
    Methods Serial changes of elevated serum IgG4 levels were examined in patients with IgG4-related systemic diseases.
    Patients Serial changes of elevated serum IgG4 levels were examined in 44 patients: AIP (n=24), Mikulicz's disease (n=8), pancreatic cancer (n=5), bile duct cancer (n=1), sclerosing cholangitis (n=1), hypereosinophilic syndrome (n=1), chronic thyroiditis (n=1), hypophysitis (n=1), idiopathic pancreatitis (n=1), and Behcet's disease (n=1).
    Results The serum IgG4 levels decreased in all patients with AIP and Mikulicz's disease after steroid therapy. The serum IgG4 levels were normalized in 46% of AIP patients and 38% of Mikulicz's disease patients. The serum IgG4 levels were not normalized at remission in 3 of 4 relapsed AIP patients, and re-elevation of serum IgG4 levels was detected in all relapsed patients. Elevated serum IgG4 levels decreased in 3 patients with pancreatic cancer after resection or chemotherapy, and decreased in patients with hypereosinophilic syndrome, sclerosing cholangitis, and hypophysitis after steroid therapy.
    Conclusion Measurement of serial serum IgG4 levels is useful to determine the disease activity of IgG4-related systemic diseases.
  • Susumu Sakamoto, Sakae Homma, Mingyon Mun, Takeshi Fujii, Atsuko Kuros ...
    2011 年 50 巻 2 号 p. 77-85
    発行日: 2011年
    公開日: 2011/01/15
    ジャーナル オープンアクセス
    Background Acute exacerbation (AE) of idiopathic interstitial pneumonia (IIP) is occasionally observed after lung surgery. However, the risk of lung surgery in patients with IIPs is not yet clearly known.
    Subjects and Methods We conducted a retrospective study of consecutive patients who underwent lung surgery for cancer or for the diagnosis of interstitial pneumonia (IP) between 2000 and 2006. Patients who developed AE following the lung operation were assessed.
    Results The data of 68 consecutive patients (males: 56, females: 12) with IP who underwent lung surgery were analyzed. The lung surgery included lobectomy for lung cancer in 48 patients [idiopathic pulmonary fibrosis (IPF) 31, non-IPF 17], and lung biopsy in 20 patients [IPF 8, non-specific interstitial pneumonia (NSIP) 8, unclassified 4]. Three patients with IPF (4.4% in total) developed AE after the operation (2 lobectomy, 1 biopsy). The triggers of AE were considered to be prolonged ventilation at a large tidal volume with oxygen supplementation at a high concentration. At the time of the AE, the extent of parenchymal involvement on the HRCT images was greater on the non-operated side. All three patients died of respiratory failure 12 to 82 days after the onset of AE despite corticosteroid therapy.
    Conclusion It is essential to be aware of the risk of AE of IPF following lung operation. Intraoperative respiratory management, such as oxygen supplementation at a high concentration and/or prolonged mechanical ventilation are likely possible etiologic factors.
  • Hiroyuki Kishi, Yoko Shibata, Daisuke Osaka, Shuichi Abe, Sumito Inoue ...
    2011 年 50 巻 2 号 p. 87-93
    発行日: 2011年
    公開日: 2011/01/15
    ジャーナル オープンアクセス
    Background Forced expiratory volume in 6 seconds (FEV6) is becoming a substitute of forced vital capacity (FVC). However, the Japanese predictive equation for FEV6 has not been established, and the validity for the use of FEV1/FEV6 for diagnosing airflow limitation in Japanese has not been confirmed.
    Methods Subjects aged 40 or older, who had participated in a community-based health check in Takahata, Japan, from 2004 through 2005, were enrolled. The smoking histories of these subjects were investigated using a self-reporting questionnaire. FVC, FEV1, and FEV6 were measured using spirometric machines. Predictive equations of FEV6 were obtained from never-smoking subjects without history of pulmonary diseases by multiple linear regression assay.
    Results FEV6 and FEV1/FEV6 were significantly correlated with FVC (r=0.998, p<0.001) and FEV1/FVC (r=0.989, p<0.001), respectively. The cutoff values of percent predicted (%) FEV6 and FEV1/FEV6 for discrimination of having the restrictive lung disorder determined by %FVC <0.8 and having the airflow limitation determined by FEV1/FVC <0.7 were 0.80 and 0.72, respectively (%FEV6: sensitivity=0.995, specificity=0.983, positive predictive value <PPV>=0.832, negative predictive value <NPV>=1.000; FEV1/FEV6: sensitivity=0.942; specificity=0.971; PPV=0.787; NPV=0.993). When the 5th percentile the lower limit of normal values was used as criterion for discrimination of having airflow limitation, sensitivity, specificity, PPV, and NPV of FEV1/FEV6 were 0.932, 0.985, 0.808, and 0.995, respectively.
    Conclusion The results of the present study suggest that %FEV6 and FEV1/FEV6 are excellent substitutes for %FVC and FEV1/FVC, respectively. We confirmed the validity of the use of FEV6 and FEV1/FEV6 for identifying pulmonary diseases in Japanese individuals.
  • Hideta Nakamura, Katsuji Teruya, Misao Takano, Kunihisa Tsukada, Junko ...
    2011 年 50 巻 2 号 p. 95-101
    発行日: 2011年
    公開日: 2011/01/15
    ジャーナル オープンアクセス
    Background The natural course of HIV-1 infection includes 10 years of an asymptomatic period before the development of AIDS. However, in Japan, the disease progression process seems faster in recent years.
    Methods The study subjects were 108 new patients with primary HIV-1 infection during the period from 1997 through 2007. We evaluated their clinical symptoms and laboratory data, and then analyzed disease progression in 82 eligible patients. Disease progression was defined as a fall in CD4 count below 350/μL and/or initiation of antiretroviral therapy.
    Results Ninety percent of the patients were infected via homosexual intercourse. All patients had at least one clinical symptom (mean; 4.75±1.99) related to primary HIV-1 infection, with a mean duration of 23.2 days (±14.8) and 53.3% of them had to be hospitalized due to severe symptoms. The mean CD4 count and viral load at first visit were 390/μL (±220.1) and 4.81 log10/mL (±0.78), respectively. None developed AIDS during the study period. Estimates of risk of disease progression were 61.0% at 48 weeks and 82.2% at 144 weeks. In patients who required antiretroviral therapy, the median CD4 count was 215/μL (range, 52-858) at initiation of such therapy. Among the patients with a CD4 count of <350/μL at first visit, 53% never showed recovery of CD4 count (>350/μL) without antiretroviral therapy.
    Conclusion Despite possible bias in patient population, disease progression seemed faster in symptomatic Japanese patients with recently acquired primary HIV-1 infection than the previously defined natural course of the disease.
  • Daiki Kobayashi, Osamu Takahashi, Gautam A. Deshpande, Takuro Shimbo, ...
    2011 年 50 巻 2 号 p. 103-107
    発行日: 2011年
    公開日: 2011/01/15
    ジャーナル オープンアクセス
    Objective Previous research suggests that sleep duration is related to metabolic syndrome, based on Western criteria. However, the criteria for metabolic syndrome vary among countries and populations. We therefore evaluated the relationship between sleep duration and the presence of metabolic syndrome in Japan.
    Methods A cross-sectional study was conducted involving 44,452 apparently healthy individuals aged 20 years or older who underwent annual health checkup the Center for Preventive Medicine at St. Luke's International Hospital in 2008. Participants were divided into 4 groups according to their average reported nightly sleep duration (<6 hours, 6-6.9 hours, 7-7.9 hours, ≥8 hours). Based on criteria by the Japan Society for the Study of Obesity, we identified individuals with metabolic syndrome. Multivariable logistic regression was used to explore the relationship adjusting for age, gender, alcohol consumption, current smoking, past medical history, and level of physical activity.
    Results The prevalence of metabolic syndrome was 8.7% (3,876/44,452; 95% CI, 8.5-9.0%). The mean age of participants was 44.8 years (SD, 12.8) and 49.5% were male. Those with sleep duration less than 6 hours were more likely to meet metabolic syndrome criteria (OR=1.42; 95% CI=1.20-1.68) than those with longer sleep duration (≥8 hours).
    Conclusion Short sleep duration is associated with the presence of metabolic syndrome despite the difference between Japanese and Western criteria.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
LETTERS TO THE EDITORS
feedback
Top